DNA Competitors

Pink Sheets . USA . 
Stock . DNA Brands
DNAX Stock  USD 0.0001  0.00  0.00%   
DNA Brands competes with Federal National, Shinhan Financial, Woori Financial, Grupo Aval, and KB Financial; as well as few others. The company conducts business under Beverages sector and is part of Consumer Staples industry. Analyzing DNA Brands competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of DNA Brands to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out DNA Brands Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of DNA Brands competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00008639.34
Details
Intrinsic
Valuation
LowRealHigh
0.000.000139.34
Details
Naive
Forecast
LowNextHigh
0.0000020.000139.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DNA Brands. Your research has to be compared to or analyzed against DNA Brands' peers to derive any actionable benefits. When done correctly, DNA Brands' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DNA Brands.

DNA Brands Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between DNA Brands and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of DNA and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of DNA Brands does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
BCH
+ 0.84
SHG
WF
+ 0.69
SHG
CIB
+ 0.68
AVAL
CIB
+ 0.65
KB
AVAL
+ 0.59
FNMFO
BCH
+ 0.58
WF
  
High negative correlations   
BCH
- 0.78
FNMFO
SHG
- 0.72
FNMFO
BCH
- 0.47
KB
CIB
- 0.36
BCH
CIB
- 0.34
SHG
KB
- 0.34
SHG

Risk-Adjusted Indicators

There is a big difference between DNA Pink Sheet performing well and DNA Brands Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DNA Brands' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

DNA Brands Competitive Analysis

The better you understand DNA Brands competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, DNA Brands' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across DNA Brands' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DNAX FNMFO SHG WF AVAL KB BAC-PL BCH CIB
 0.00 
 0.0001 
DNA
 0.00 
 33,000 
Federal
 0.73 
 38.86 
Shinhan
 0.34 
 35.86 
Woori
 1.90 
 2.15 
Grupo
 0.25 
 68.76 
KB Financial
 0.50 
 1,251 
Bank
 0.61 
 22.94 
Banco
 0.15 
 32.65 
Bancolombia
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Very steady
Slightly risky
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Good
Good
Very Weak
Very Weak
Modest
Modest
Weak
Very Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Low
Low
Very Low
Low
Low
Very Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Strong Buy
Hold
Strong Buy
Not Available
Buy
Hold
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Hold
Strong Hold
Buy
Hold
Hold
Buy
Strong Buy
Current Ratio
0.01
242.68
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Asset
N/A
4.23 T
691.8 T
498 T
301.18 T
715.74 T
3.05 T
55.84 T
342.93 T
Profit Margin
N/A
N/A
0.31
0.26
0.0433
0.32
0.3
0.49
0.28
EBITDA
(239.66 K)
98.04 B
1.01 T
4.4 T
(270 B)
(383.07 B)
40.61 B
(1.93 B)
10.27 T
Operating Margin
-0.98
N/A
0.15
0.42
0.3
0.59
0.34
0.57
0.39
Current Valuation
1.47 M
52.83 T
49.5 T
48.93 T
47.59 T
43.26 T
11.54 T
9.71 T
9.61 T
Price To Book
N/A
N/A
0.49
0.37
0.65
0.62
N/A
2.05
0.85
Retained Earnings
(30.44 M)
N/A
36.39 T
24.99 T
7.73 T
32.03 T
N/A
2.69 T
8.63 T
Current Asset
319 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Five Year Return
N/A
N/A
3.8
N/A
6.04
N/A
5.89
4.13
3.1
Beta
1.14
2.06
0.61
0.66
0.5
0.59
1.4
0.2
1.1
Number Of Employees
1
7.4 K
N/A
77
N/A
141
216.82 K
N/A
33.89 K
Shares Outstanding
22.07 K
5.74 B
503.44 M
247.51 M
377.11 M
374.49 M
N/A
505.08 M
113.03 M
Cash Flow From Operations
(1.1 M)
47.21 B
1.91 T
1.62 T
1.81 T
4.11 T
(7.19 B)
1.73 T
2.13 T
Annual Yield
N/A
N/A
0.0402
0.0764
0.0561
0.044
0.0591
0.0713
0.0985
Total Debt
2 M
4.16 T
125.99 T
75.08 T
65.54 T
121.39 T
275.98 B
16.36 T
33.75 T
Return On Equity
N/A
0.33
0.0809
0.083
0.051
0.0736
0.1
0.27
0.15
Book Value Per Share
-0.92
-14.14
100028.0
37313.36
706.83
137053.0
30.61
54.2
42522.65
Return On Asset
N/A
0.0039
0.0065
0.0057
0.0052
0.006
0.0089
0.0267
0.0177
Number Of Shares Shorted
N/A
N/A
273.66 K
78.74 K
60.18 K
338.49 K
2.72 K
454.6 K
353.15 K
Current Liabilities
3.43 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
327 K
4.23 T
691.8 T
498 T
301.18 T
715.74 T
3.05 T
55.84 T
342.93 T
Short Ratio
N/A
N/A
2.1
1.14
2.04
1.97
0.45
2.62
1.41
Target Price
N/A
N/A
52.31
67267.52
3.0
120069.0
N/A
25.44
34.17
Last Dividend Paid
N/A
N/A
3195.0
N/A
N/A
N/A
0.86
8.08
N/A
Debt To Equity
N/A
N/A
N/A
N/A
14.32
10.47
N/A
10.64
7.12
Shares Owned By Institutions
N/A
19.1
3.43
2.78
0.49
5.36
65.5
2.27
23.03
Market Capitalization
33.98 K
2.27 B
19.56 B
9.01 B
2.45 B
25.85 B
241.31 B
11.61 B
8.12 B
Price To Earning
0.2
N/A
4.62
6.0
3.11
4.13
496.8
10.27
4.46
Price To Earnings To Growth
N/A
N/A
5.1
2.46
N/A
0.71
N/A
1.86
1.65
Price To Sales
0.11
0.087
0.0013
9.0E-4
2.0E-4
0.0019
2.57
0.004
4.0E-4
Net Income
(1.25 M)
22.18 B
4.37 T
2.63 T
3.49 T
4.63 T
27.53 B
1.37 T
6.12 T
Earnings Per Share
0.02
0.007
6.24
7.41
0.16
8.3
3.51
2.91
5.72
Revenue
249.01 K
31.45 B
14.18 T
9.5 T
11.71 T
13.08 T
94.95 B
2.81 T
20.88 T
Working Capital
(3.12 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash And Equivalents
499
118.91 B
79.61 T
37.77 T
17.33 B
85.9 T
725.06 B
7.51 B
5.9 B
Cash Per Share
N/A
20.72
N/A
N/A
15.55
N/A
77.61
14.86
27.37
Gross Profit
249.01 K
24.45 B
25.67 T
9.98 T
13.61 T
13.18 T
92.41 B
2.64 T
20.63 T
Day Typical Price
1.0E-4
33000.0
38.86
35.81
2.14
68.68
1248.54
22.87
32.65
Accumulation Distribution
N/A
N/A
0.0064
0.0095
0.0323
0.0103
0.0051
0.0126
0.011
Market Facilitation Index
N/A
N/A
0.25
0.34
0.07
0.71
6.44
0.29
0.36
Daily Balance Of Power
0.0
0.0
1.12
0.3529
0.5714
(0.24)
0.9612
0.4828
(0.14)
Period Momentum Indicator
N/A
N/A
0.28
0.12
0.04
(0.17)
6.19
0.14
(0.05)
Rate Of Daily Change
1.0
1.0
1.01
1.0
1.02
1.0
1.0
1.01
1.0
Day Median Price
1.0E-4
33000.0
38.85
35.79
2.13
68.65
1247.47
22.84
32.65
Price Action Indicator
N/A
N/A
0.15
0.13
0.035
0.03
6.32
0.18
(0.03)
Coefficient Of Variation
742.02
711.44
(1,692)
(7,004)
1342.7
2239.21
2167.9
(917.06)
2809.25
Mean Deviation
22.96
5.7
1.62
1.28
1.1
1.78
0.467
0.913
1.2
Jensen Alpha
5.02
1.94
(0.24)
(0.08)
0.0884
0.003
0.03
(0.19)
(0.01)
Total Risk Alpha
(0.59)
(0.14)
(0.49)
(0.30)
(0.12)
(0.26)
(0.08)
(0.32)
(0.19)
Sortino Ratio
0.0977
0.143
N/A
N/A
(0.01)
(0.01)
(0.15)
N/A
(0.04)
Downside Variance
2812.5
163.43
N/A
N/A
2.5
5.1
0.385
N/A
2.61
Standard Deviation
39.35
13.89
2.3
1.79
1.52
2.4
0.6379
1.2
1.55
Kurtosis
1.98
39.1
4.63
3.07
1.27
1.68
1.27
0.8299
0.9016
Potential Upside
100.0
16.33
3.28
2.47
2.51
4.07
1.06
1.86
2.87
Treynor Ratio
2.24
38.4
(0.17)
(0.09)
0.7827
0.1179
(0.21)
(0.33)
0.0994
Maximum Drawdown
150.0
118.39
14.09
12.54
7.56
12.49
3.19
6.77
8.05
Variance
1548.37
193.02
5.27
3.2
2.32
5.78
0.4069
1.44
2.4
Market Risk Adjusted Performance
2.25
38.41
(0.16)
(0.08)
0.7927
0.1279
(0.20)
(0.32)
0.1094
Risk Adjusted Performance
0.1128
0.1168
(0.04)
(0.01)
0.0619
0.0409
0.0333
(0.08)
0.0323
Skewness
1.37
5.54
0.9867
0.1215
0.1741
0.6654
0.1541
(0.33)
(0.23)
Semi Deviation
19.73
4.34
N/A
N/A
1.19
2.16
0.5663
N/A
1.57
Information Ratio
0.1316
0.1316
(0.11)
(0.08)
(0.01)
(0.01)
(0.15)
(0.21)
(0.04)
Value At Risk
(50.00)
(8.65)
(3.84)
(2.43)
(2.37)
(3.25)
(0.96)
(2.35)
(2.25)
Expected Short fall
(100.00)
(20.76)
N/A
N/A
(1.62)
(1.83)
(0.50)
N/A
(1.22)
Downside Deviation
53.03
12.78
N/A
N/A
1.58
2.26
0.6204
N/A
1.61
Semi Variance
389.34
18.81
N/A
N/A
1.41
4.67
0.3207
N/A
2.46

DNA Brands Competition Performance Charts

Five steps to successful analysis of DNA Brands Competition

DNA Brands' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by DNA Brands in relation to its competition. DNA Brands' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of DNA Brands in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact DNA Brands' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to DNA Brands, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your DNA Brands position

In addition to having DNA Brands in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for DNA Pink Sheet Analysis

When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY